Novavax Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	240.63	530.23	568.51	1,337	1,515
Short-Term Investments	494.45	392.89	-	-	-
Cash & Short-Term Investments	735.08	923.12	568.51	1,337	1,515
Cash Growth	-20.37%	62.38%	-57.48%	-11.76%	113.08%
Receivables	106.45	108.29	297.24	82.38	454.99
Inventory	11.55	8.75	41.7	36.68	8.87
Prepaid Expenses	26.82	56.28	70.3	160.77	120.03
Restricted Cash	10.88	10.63	10.42	10.3	11.49
Other Current Assets	87.51	21.89	155.73	76.37	44.62
Total Current Assets	978.28	1,129	1,144	1,703	2,155
Property, Plant & Equipment	67.7	300	490.99	400.49	265.86
Goodwill	113.46	107.48	127.45	126.33	131.48
Other Long-Term Assets	17.08	24	35.16	28.47	24.29
Total Assets	1,177	1,560	1,797	2,259	2,577
Accounts Payable	24.58	41.58	132.61	216.52	127.05
Accrued Expenses	107.17	134.09	291.55	591.16	673.73
Current Portion of Long-Term Debt	-	-	-	324.88	-
Current Portion of Leases	2.51	17.1	28.12	44.06	161.52
Current Unearned Revenue	140.05	675.07	241.31	370.14	1,423
Other Current Liabilities	185.65	286.58	941.55	913.19	5.08
Total Current Liabilities	459.95	1,154	1,635	2,460	2,390
Long-Term Debt	244.21	169.68	168.02	166.47	323.46
Long-Term Leases	2.09	76.68	84.5	81.32	39.12
Long-Term Unearned Revenue	358.94	446.82	622.21	179.41	172.53
Other Long-Term Liabilities	239.07	336.66	4.55	5.61	3.01
Total Liabilities	1,304	2,184	2,514	2,893	2,928
Common Stock	1.65	1.62	1.41	0.87	0.76
Additional Paid-In Capital	4,540	4,501	4,192	3,738	3,352
Retained Earnings	-4,568	-5,008	-4,821	-4,276	-3,618
Treasury Stock	-103.02	-95.85	-92.27	-90.66	-85.1
Comprehensive Income & Other	2.01	-22.56	2.72	-6.38	-1.35
Shareholders' Equity	-127.75	-623.84	-716.93	-634.08	-351.67
Total Liabilities & Equity	1,177	1,560	1,797	2,259	2,577
Total Debt	248.81	263.47	280.64	616.73	524.09
Net Cash (Debt)	486.27	659.65	287.87	720.15	991.03
Net Cash Growth	-26.28%	129.15%	-60.03%	-27.33%	332.45%
Net Cash Per Share	2.81	4.33	2.86	9.21	13.32
Filing Date Shares Outstanding	162.94	160.84	139.95	86.17	76.28
Total Common Shares Outstanding	162.58	160.42	139.51	86.04	75.84
Working Capital	518.33	-25.47	-491.25	-756.55	-235.2
Book Value Per Share	-0.79	-3.89	-5.14	-7.37	-4.64
Tangible Book Value	-241.22	-731.32	-844.38	-760.41	-483.15
Tangible Book Value Per Share	-1.48	-4.56	-6.05	-8.84	-6.37
Land	-	14.95	102.92	101.34	83.53
Machinery	-	66.23	153.36	139.74	122.61
Construction In Progress	-	39.51	76.16	81.57	35.11
Leasehold Improvements	-	66.89	48.31	18.9	10.28

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q